| ²é¿´: 1229 | »Ø¸´: 4 | |||
andana½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÌØÁ¢·ú°·µÄCASºÅ ÒÑÓÐ1È˲ÎÓë
|
| ÇëÎʸ÷λCASºÅ108605-62-5ºÍCASºÅ16345-81-8µ½µ×ÄĸöÊÇÌØÁ¢·ú°·µÄCASºÅ°¡£¿ÕâÁ½¸ö½á¹¹Ê½ÓÐÊ²Ã´Çø±ðÄØ£¿ |
» ²ÂÄãϲ»¶
ÖйúÒ©¿Æ´óѧ2026Èëѧ²©Ê¿£¬Ò©ÎïºÏ³ÉºÍÉè¼Æ¾Ñ飬·ÅÉ仯ѧ¼°·ÅÉäҽѧÑо¿
ÒѾÓÐ25È˻ظ´
ʹÓÃMolAICal½øÐжàëÄÐéÄâɸѡ½Ì³Ì-ͬÑùÊÊÓÃÓÚµ°°×ÖʺͺËËáµÄÐéÄâɸѡ
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ203È˻ظ´
ʹÓÃMolAICal¼ÆËãÒ©Îﻯѧ¹ýÂËÆ÷MCFs¼°MCE-18ÃèÊö·û
ÒѾÓÐ0È˻ظ´
ʹÓÃMolAICal·¢ÏÖµ°°×ÊÜÌåDZÔڵĻîÐÔ¿Ú´ü¼°Î»µã
ÒѾÓÐ0È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ10È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ2È˻ظ´
26É격×Ô¼ö
ÒѾÓÐ12È˻ظ´
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
2Â¥2017-03-03 13:32:43
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
|
Title: Teriflunomide CAS Registry Number: 163451-81-8; 108605-62-5 (unspecified stereo) CAS Name: (2Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide Manufacturers' Codes: A-771726 Molecular Formula: C12H9F3N2O2 Molecular Weight: 270.21 Percent Composition: C 53.34%, H 3.36%, F 21.09%, N 10.37%, O 11.84% Literature References: Disease modifying antirheumatic drug (DMARD); active metabolite of leflunomide, q.v. Prepn: R. R. Bartlett, F.-J. Kämmerer, WO 9117748; eidem, US 5494911 (1991, 1996 both to Hoechst). Identification as active metabolite: J. W. Patterson et al., J. Med. Chem. 35, 507 (1992). Phamacokinetics: J. Lucien et al., Ther. Drug Monit. 17, 454 (1995). Inhibits dihydroorotate dehydrogenase: J. P. Davis et al., Biochemistry 35, 1270 (1996). Configurational study: G. Bertolini et al., J. Med. Chem. 40, 2011 (1997); and crystal structure: C. Papageorgiou et al., Bioorg. Chem. 25, 233 (1997). HPLC determn in plasma: V. Chan et al., J. Chromatogr. B 803, 331 (2004). Therap-Cat: Immunomodulator; in treatment of multiple sclerosis. Keywords: Immunomodulator. |
3Â¥2017-03-03 13:33:27
andana
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1589.5
- É¢½ð: 38
- ºì»¨: 1
- Ìû×Ó: 97
- ÔÚÏß: 185.3Сʱ
- ³æºÅ: 1027074
- ×¢²á: 2010-05-24
- רҵ: É«Æ×·ÖÎö
4Â¥2017-03-03 13:45:01
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
5Â¥2017-03-03 15:32:22














»Ø¸´´ËÂ¥